Applied Therapeutics, Inc. — Director's Dealing 2022

Oct 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-10-13

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-13	Common Stock	P	73256	$0.5582	Acquired	717495	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1750000	Indirect
Common Stock	1492094	Indirect
Common Stock	709720	Indirect
Common Stock	290280	Indirect
Common Stock	88397	Indirect

Footnotes

F1: These shares were purchased by Dr. Shendelman in multiple transactions.

F2: Weighted average price. These shares were purchased by Dr. Shendelman in multiple transactions at prices ranging from $0.512 to $0.5768 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3: Through a grantor retained annuity trust.

F4: Through a family trust controlled by the reporting person's spouse.

F5: Through the reporting person's spouse.

F6: Through a family trust controlled by the reporting person.

F7: Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.